A Phase 2 interventional study of Modafinil 200mg and mixed amphetamine salts in Cognition, sponsored by United States Army Aeromedical Research Laboratory. Status unknown at 1 site in United States. Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-31.
Sponsored by United States Army Aeromedical Research Laboratory · Phase 2, Interventional, and Other
Considerable research has documented the optimization utility of stimulants in sleep deprived Soldiers and aviators, however, the research for enhancement purposes has demonstrated mixed results. One significant factor that may influence enhancement properties is general intelligence such that low performers exhibit stronger enhancement effects than high performers. The objective of this study is to determine whether stimulants (specifically, modafinil and Adderall) can enhance Soldier cognitive abilities and performance on military tasks. To do so, a within-subjects design will be employed using healthy, rested Soldiers and measuring performance on a set of basic cognitive assessments and operationally relevant tasks.
United States Army Aeromedical Research Laboratory is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
single, 200 mg dose of modafinil
Drug: Modafinil 200mg
single 10 mg dose of mixed amphetamine salts
Drug: mixed amphetamine salts
placebo
Drug: Placebo
single 200 mg dose
single 10 mg dose
single oral-administration placebo tablet
change from baseline in working memory performance
Digit span task
Time frame: 2-hours post-dosing
change from baseline in selective attention performance
Stroop test
Time frame: 2-hours post-dosing
change from baseline in sustained attention performance
Rapid Visual Information Processing Task
Time frame: 2-hours post-dosing
change from baseline in executive function performance
Digit symbol substitution task
Time frame: 2-hours post-dosing
change from baseline in marksmanship performance
number of targets acquired on marksmanship trainer
Time frame: 2-hours post-dosing
change from baseline in impulsivity
Stop signal task - response inhibition
Time frame: 2-hours post-dosing
change from baseline in impulsivity
Continuous Performance test - rapid response initiation
Time frame: 2-hours post-dosing
change from baseline in risk-taking behavior
Evaluation of Risks Scale; measures individual variability in risk assessment; three scores are produced ("need for control", "self-confidence", "risk/thrill seeking"), all scores range from 0 to 100 with higher scores indicating a higher degree of the construct (e.g., higher risk/thrill seeking scores indicate a greater degree of risk/thrill seeking)
Time frame: 2-hours post-dosing
Documents are hosted by the registry — open the source record to download them.
This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
United States Army Aeromedical Research Laboratory